Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
News
News
Most popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Roman Perez-Soler, MD
lungcanc
Vinicius Ernani, MD
Breaking News Briefs
Scott Antonia, MD, PhD
Glen Weiss, MD, MBA
Karen Kelly, MD
lungcanc
Fabrice Barlesi, MD
lungcanc
Dr. Chandra P. Belani Named New Chief Science Officer for the...
lungcanc
Cathy Pietanza, MD
lungcanc
John C. Ruckdeschel, MD
lungcanc
Robert L. Comis, MD
lungcanc
Dr. David J. Sugarbaker
lungcanc
Stefania Vallone
lungcanc
Robert J. Cerfolio, MD, MBA
lungcanc
Laurie E. Gaspar, MD, MBA
lungcanc
1
2
3
...
13
Page 1 of 13
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
